Published Medical Journal Articles Concerning HRT Revealed to Be “Ghostwritten”
Recently disclosed court documents reveal that Wyeth, the pharmaceutical giant behind hormone replacement medications Premarin and Prempro,has played a “major role” in 26 scientific articles published...
View ArticleNew Bill Proposes to End Foreign Manufacturer Tort Liability Loopholes
Each year, many people in the United States are injured by defective foreign products imported into the United States.
View ArticleTroubling Ghostwriting Survey Prompts New Medical Journal Policies
A survey released by The Journal of the American Medical Association (JAMA) concludes that six of the top medical journals in the U.S. published a “significant number” of ghostwritten articles in...
View ArticleFDA’s Oversight of Post-Marketing Studies Inadequate
The Government Accountability Office (GAO) has released a new report about the FDA’s lack of post-marketing oversight in a number of the drugs which it conditionally approved.
View ArticlePfizer Pleads Guilty to Criminally Illegal Marketing
Earlier this month, drug giant Pfizer agreed to pay a $2.3 billion penalty to settle claims over payment of kickbacks and illegal drug marketing and promotion that violated federal drug laws over an...
View ArticleThe FDA Must Improve Communication to Patients
The American Recovery and Reinvestment Act allocated $1.1 billion dollars to coordinate research and guide investments in comparative research funded by the Act.
View ArticleFDA Begins to Update Post-Market Procedures, Though Still Lacking
The Government Accountability Office (GAO) has compiled a report looking at the steps the FDA has been taking to improve communication between the internal offices of the FDA, in an effort to protect...
View ArticleQuestionable Evidence Used in FDA Approval of Cardiovascular Devices
Dr. Rita Redberg and her colleagues at the UCSF Medical Center have published a startling report regarding the FDA’s approval of cardiovascular drugs. According to the report, from 2000-2007 the FDA...
View ArticleMore Woes for Medtronic and FDA as ICD Leads Continue to Fail
For patients with a high risk of cardiac-related death, implantable cardioverter-defibrillators (ICDs) are usually a demonstrably favorable alternative to medication.
View ArticleLong-Term Hospitals Offer Lackluster Care, Huge Profits
In traditional hospitals, patients have an attending physician or doctors on staff to treat them in the event that their condition worsens. Unfortunately, Medicare loopholes have created an industry of...
View ArticleAvandia Scandal Continues to Unfold
Avandia is a prescription drug marketed by GlaxoSmithKline (GSK). Released to the U.S. market in 1999, Avandia has been used by millions of Americans to treat Type II diabetes.
View ArticleAdvisory Panel Says FDA Needs Recall Power
The FDA oversees the regulation of medical devices and more than $1 trillion annually worth of food, drugs, dog food, cosmetics, and other products.
View ArticleClinical Trial Participants get little FDA protection
Millions of patients enroll in clinical trials every year for experimental drugs and medical devices, but a federal investigation conducted by Inspector General Daniel R. Levinson of the Department of...
View ArticleFDA Appoints Members of Risk Communication Panel
The FDA has created a new 15-member advisory panel to advise the agency about the best methods to educate consumers about the risks and benefits about the products it regulates.
View ArticleFDA Plans to Accelerate Generic Drug Review
The FDA has revealed a new program designed to speed up the approval process of generic drugs. The new drug review program called Generic Initiative for Value and Efficacy (GIVE) aims to significantly...
View ArticleGE Facing Litigation Over MRI Drug Omniscan
Litigation is mounting against General Electric Co. over Omniscan, an allegedly toxic injectable contrast agent used in MRI. Omniscan, or gadodiamide, is widely popular injectable used in patients...
View ArticleMerck Sued by State of New York over Vioxx
Last month, the state and city of New York sued Merck & Co., Inc., the maker of the blockbuster drug Vioxx, for tens of millions of dollars paid by Medicaid and similar state programs for Vioxx...
View ArticleOff–Label Use of Drugs
Many physicians are prescribing drugs for "off-label" uses - for conditions and symptoms other than the drug was designed to treat.
View ArticleState Suing Drug Companies for Fraud
This month, Iowa became the latest state to sue 78 major drug companies for fraud and recover millions of dollars that was lost through a “grotesque abuse of the Medicaid reimbursement system,”...
View ArticleUnderstaffing Endangering Lives
In a recent report, the Department of Health and Human Services concluded that most nursing homes are understaffed to the point of endangering their residents.
View Article
